FUNGAL INFECTION
Clinical trials for FUNGAL INFECTION explained in plain language.
Never miss a new study
Get alerted when new FUNGAL INFECTION trials appear
Sign up with your email to follow new studies for FUNGAL INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug trial aims to shield vulnerable transplant patients from deadly fungal infections
Prevention OngoingThis study is testing if a new intravenous drug called Rezafungin works as well as or better than the current standard medications to prevent dangerous fungal infections. It involves 602 adults who are receiving a donor bone marrow transplant for conditions like leukemia. The mai…
Matched conditions: FUNGAL INFECTION
Phase: PHASE3 • Sponsor: Mundipharma Research Limited • Aim: Prevention
Last updated Apr 01, 2026 21:56 UTC
-
New drug trial aims to shield transplant patients from deadly fungal infections
Prevention ENROLLING_BY_INVITATIONThis study is testing whether a new antifungal drug called rezafungin can prevent serious fungal infections in liver transplant patients who are at high risk. About 385 patients will receive either rezafungin or standard antifungal medications, and researchers will compare infect…
Matched conditions: FUNGAL INFECTION
Phase: PHASE3 • Sponsor: Fernanda P Silveira, MD, MS • Aim: Prevention
Last updated Mar 31, 2026 12:12 UTC
-
Researchers investigate deadly fungal threat in vulnerable liver patients
Knowledge-focused OngoingThis study aims to better understand why some critically ill liver cirrhosis patients develop a dangerous fungal lung infection called invasive pulmonary aspergillosis. Researchers will examine 450 patients to identify specific risk factors and improve early detection. By compari…
Matched conditions: FUNGAL INFECTION
Sponsor: Universitaire Ziekenhuizen KU Leuven • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:12 UTC